Alfasigma USA Revenue and Competitors

Covington, LA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Alfasigma USA's estimated annual revenue is currently $57.1M per year.(i)
  • Alfasigma USA's estimated revenue per employee is $201,000

Employee Data

  • Alfasigma USA has 284 Employees.(i)
  • Alfasigma USA grew their employee count by 26% last year.

Alfasigma USA's People

NameTitleEmail/Phone
1
Sales Training SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M11-8%$28.7MN/A
#2
$5.8M290%N/AN/A
#3
$7.6M386%N/AN/A
#4
$13.9M6917%N/AN/A
#5
$29.9M14930%N/AN/A
#6
$101.5M505-9%N/AN/A
#7
$10.5M520%N/AN/A
#8
$1.6M833%N/AN/A
#9
$43.8M21821%N/AN/A
#10
$12.3M6117%N/AN/A
Add Company

What Is Alfasigma USA?

Pamlab, formerly part of Nestle Health Sciences, is now Alfasigma USA. Alfasigma USA, Inc. distributes a portfolio of prescription nutritional products to help individuals who are suffering from GI disorders (VSL#3®), major depressive disorder (Deplin®), diabetic peripheral neuropathy (Metanx®), and mild cognitive impairment (CerefolinNAC®). Through the company's commitment to improving patients health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Alfasigma USA has corporate headquarters in Covington, LA and a newly opened commercial hub in Bedminster, NJ. Discover Alfasigma USA at http://www.alfasigmausa.com.

keywords:N/A

N/A

Total Funding

284

Number of Employees

$57.1M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alfasigma USA News

2022-04-06 - Medical Foods Market 2022 Analysis by Key Players, Trends, Demand, Products and Suppliers Forecast to 2026

Alfasigma USA, Inc. ... The U.S. is a frontrunner in the medical foods industry, ... 7th Floor, New York City, NY 10007 United States

2022-04-06 - The next 10 years to witness a digitally topsy-turvy scenario in ...

Alfasigma USA, Inc. ... The U.S. is a frontrunner in the medical foods industry, ... 7th Floor, New York City, NY 10007 United States

2019-09-08 - Alfasigma brings Zelnorm back to US market

The US subsidiary of Italian drugmaker Alfasigma yesterday announced that Zelnorm (tegaserod) is now available in the USA as a prescription ...

2019-09-03 - Global Irritable Bowel Syndrome (IBS) Market Size 2019 ...

... market are Allergan Plc (Ireland), Sucampo Pharmaceuticals (U.S.), ... Sebela Pharmaceuticals (Ireland), Probi (Sweden), Alfasigma USA, ...

2019-09-03 - Alfasigma USA Announces ZELNORM™ (tegaserod) Now ...

Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M28410%N/A
#2
$83.3M303-6%N/A
#3
$78.4M3127%N/A
#4
$35M335-2%N/A
#5
$35M3693%N/A